<DOC>
	<DOCNO>NCT02861560</DOCNO>
	<brief_summary>A prospective case series investigate efficacy safety dehydrate human amnion/chorion membrane ( dHACM ) treatment patient Stage II III pressure ulcer</brief_summary>
	<brief_title>Case Series Weekly Applications dHACM Treatment Pressure Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>1 . Index ulcer characteristic : 1 . Ulcer present ≥ 30 day ( Day 0 ) 2 . Index ulcer locate spine , low back buttocks 3 . Index ulcer area debridement ≥ 2 cm² ≤ 25 cm² randomization visit 4 . Ulcer must Stage II III determine National Pressure Ulcer Advisory Panel ( NPUAP ) pressure ulcer stag system 2 . Subject criterion must include : 1 . Age 16 old 2 . The subject willing able provide inform consent participate procedure followup evaluation necessary complete study ( minor provide assent consent provide parent ) 1 . Index ulcer characteristic make subject ineligible enrollment : 1 . Stage I IV ulcer determine NPUAP pressure ulcer stag system 2 . Signs symptoms local infection 3 . Previous surgical procedure perform site 4 . Known suspected local skin malignancy index ulcer site 5 . Prior radiation therapy treatment index ulcer site 2 . Subject criterion make subject ineligible enrollment : 1 . Presence disease , Opinion Investigator , may result allograft failure experience graft failure past ( example include : immune system disorder include Systemic Lupus Erythematosus ( SLE ) , Fibromyalgia , Acquired Immunodeficiency Syndrome ( AIDS ) HIV ) 2 . Currently take medication opinion investigator may affect graft incorporation 3 . Allergy known sensitivity Aminoglycosides gentamicin sulfate and/or streptomycin sulfate 4 . Any condition ( ) opinion investigator may seriously compromise subject 's ability participate study . Examples include : known history poor adherence medical treatment , current drug alcohol abuse medical/psychiatric condition 5 . Pregnancy enrollment within last 6 month , woman breastfeed , woman childbearing potential planning become pregnant time study OR unwilling/unable use acceptable method contraception ( birth control pill , barrier , abstinence ) 6 . Subjects currently enrol study ( i.e . concurrent enrollment study prohibit ) 7 . Subject use investigational drug ( ) therapeutic device ( ) within 30 day precede screening . 8 . Any pathology would limit blood supply compromise heal 9 . Subject prisoner</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>